KKR Sinks Its Teeth Into Henry Schein With Additional Investment And Board Seats: Details
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds affiliated with KKR & Co.
Analysts at Barrington Research cut their Q1 2025 earnings estimates for shares of Henry Schein in a research report issued ...
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
Shares of Henry Schein Inc. advanced 4.95% to $79.87 Wednesday, on what proved to be an all-around poor trading session for ...
Henry Schein (NASDAQ:HSIC – Free Report) had its price objective hoisted by Barrington Research from $82.00 to $90.00 in a research note published on Thursday,Benzinga reports. They currently have an ...
Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein ...
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback